B cell tolerance: Putting the horse before the cart

Arthritis and Rheumatism

Volumn 63, Issue 5, 2011, Pages 1173-1176

  Kelsoe, Garnett ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; B LYMPHOCYTE; EDITORIAL; GENE REARRANGEMENT; GENETIC VARIABILITY; HUMAN; IMMUNOGLOBULIN STRUCTURE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE;

EID: 79955566181     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30162     Document Type: Editorial

References (39)

1. Menard L, Samuels J, Ng YS, Meffre E,. Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis. Arthritis Rheum 2011; 63: 1237-45.
2. Rajewsky K,. Clonal selection and learning in the antibody system. Nature 1996; 381: 751-8. (Pubitemid 26243107)
3. Von Boehmer H, Melchers F,. Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 2010; 11: 14-20.
4. Nemazee DA, Burki K,. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989; 337: 562-6. (Pubitemid 19045542)
5. Erikson J, Radic MZ, Camper SA, Hardy RR, Carmack C, Weigert M,. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 1991; 349: 331-4. (Pubitemid 21912076)
6. Tiegs SL, Russell DM, Nemazee D,. Receptor editing in self-reactive bone marrow B cells. J Exp Med 1993; 177: 1009-20. (Pubitemid 23097390)
7. Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988; 334: 676-82.
8. Halverson R, Torres RM, Pelanda R,. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat Immunol 2004; 5: 645-50. (Pubitemid 38811890)
9. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR,. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 2001; 167: 6834-40. (Pubitemid 33144175)
10. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC,. Predominant autoantibody production by early human B cell precursors. Science 2003; 301: 1374-7. (Pubitemid 37075812)
11. Wardemann H, Nussenzweig MC,. B-cell self-tolerance in humans. Adv Immunol 2007; 95: 83-110. (Pubitemid 47381589)
12. Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, Wardemann H,. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods 2008; 329: 112-24. (Pubitemid 350235462)
13. Hayakawa K, Ishii R, Yamasaki K, Kishimoto T, Hardy RR,. Isolation of high-affinity memory B cells: phycoerythrin as a probe for antigen-binding cells. Proc Natl Acad Sci U S A 1987; 84: 1379-83. (Pubitemid 17027357)
14. McHeyzer-Williams MG, Nossal GJ, Lalor PA,. Molecular characterization of single memory B cells. Nature 1991; 350: 502-5. (Pubitemid 21912263)
15. Jacob J, Kelsoe G, Rajewsky K, Weiss U,. Intraclonal generation of antibody mutants in germinal centres. Nature 1991; 354: 389-92. (Pubitemid 21896846)
16. Kuppers R, Zhao M, Hansmann ML, Rajewsky K,. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993; 12: 4955-67. (Pubitemid 23358484)
17. Meffre E, Schaefer A, Wardemann H, Wilson P, Davis E, Nussenzweig MC,. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J Exp Med 2004; 199: 145-50. (Pubitemid 38076487)
18. Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005; 201: 703-11. (Pubitemid 40395116)
19. Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E,. Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 2005; 201: 1659-67. (Pubitemid 40721009)
20. Herve M, Isnardi I, Ng YS, Bussel JB, Ochs HD, Cunningham-Rundles C, et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med 2007; 204: 1583-93. (Pubitemid 47048025)
21. Ichiyoshi Y, Casali P,. Analysis of the structural correlates for self-antigen binding by natural and disease-related autoantibodies: in vitro expression of recombinant and/or mutagenized human IgG. Ann N Y Acad Sci 1995; 764: 328-41. (Pubitemid 26136180)
22. Crouzier R, Martin T, Pasquali JL,. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors. J Immunol 1995; 154: 4526-35.
23. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A,. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003; 19: 837-47. (Pubitemid 37542304)
24. Gu H, Tarlinton D, Muller W, Rajewsky K, Forster I,. Most peripheral B cells in mice are ligand selected. J Exp Med 1991; 173: 1357-71.
25. Russell DM, Dembic Z, Morahan G, Miller JF, Burki K, Nemazee D,. Peripheral deletion of self-reactive B cells. Nature 1991; 354: 308-11. (Pubitemid 21896883)
26. Loder F, Mutschler B, Ray R, Paige C, Sideras P, Torres R, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 1999; 190: 75-89. (Pubitemid 29330125)
27. Levine MH, Haberman AM, Sant'Angelo DB, Hannum LG, Cancro MP, Janeway CA Jr, et al. A B-cell receptor-specific selection step governs immature to mature B cell differentiation. Proc Natl Acad Sci U S A 2000; 97: 2743-8. (Pubitemid 30159242)
28. Pulendran B, Kannourakis G, Nouri S, Smith KG, Nossal GJ,. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 1995; 375: 331-4.
29. Shokat KM, Goodnow CC,. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 1995; 375: 334-8.
30. Han S, Zheng B, Dal Porto J, Kelsoe G,. In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J Exp Med 1995; 182: 1635-44.
31. Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H,. Autoreactivity in human IgG+ memory B cells. Immunity 2007; 26: 205-13. (Pubitemid 46329436)
32. Haynes BF, Fleming J, St.Clair EW, Katinger H, Stiegler G, Kunert R, et al. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 2005; 308: 1906-8. (Pubitemid 40941873)
33. Mouquet H, Scheid JF, Zoller MJ, Krogsgaard M, Ott RG, Shukair S, et al. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 2010; 467: 591-5.
34. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19: 56-9. (Pubitemid 28242023)
35. Chen Z, Koralov SB, Kelsoe G,. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med 2000; 192: 1339-52.
36. Khan SN, Witsch EJ, Goodman NG, Panigrahi AK, Chen C, Jiang Y, et al. Editing and escape from editing in anti-DNA B cells. Proc Natl Acad Sci U S A 2008; 105: 3861-6. (Pubitemid 351723490)
37. Monroe RJ, Seidl KJ, Gaertner F, Han S, Chen F, Sekiguchi J, et al. RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. Immunity 1999; 11: 201-12. (Pubitemid 29428813)
38. Ueda Y, Kondo M, Kelsoe G,. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med 2005; 201: 1771-80. (Pubitemid 41002896)
39. Littman DR, Rudensky AY,. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010; 140: 845-58.